Call us toll free:
A non-drug therapy for the treatment of anxiety, depression, and insomnia
with a pulse rate frequency of 100 Hz
CES, (cranial electrotherapy stimulation) employs mild electrical stimulation, and helps restore emotional balance, for optimum pre-stress functioning in a safe, non-addictive, and affordable manner.
Health Pax is backed by extensive scientific research. In fact, Health Pax outputs the original 100 Hz. configuration upon which most of this research is based.
Health Pax is FDA approved as a Class III cranial electrotherapy stimulator (CES) device through the 510(k) premarket notification process, for the intended use described in Title 21, Code of Federal Regulations, Part 882.5800: “A cranial electrotherapy stimulator is a device that applies electrical current to a patient’s head to treat insomnia, depression, or anxiety.”
A sampling of research abstracts available on CES
Weiss, M.F. The treatment of insomnia
through electrosleep, J Nerv & Ment.Dis. 157(2): 108-120,
Long term follow up of insomnia treatment
Cartwright, R.D. & Weiss, M. F. The effects of electrosleep on insomnia revisited, J Nerv & Ment. Dis. 161 (2): 134-137, 1975.
Two year follow up done at U of Ill. of Weiss's. The treatment of patients, with the exception of 1 person, continued to be free of insomnia 2 years later. Of the sham treated group, 4 had difficulty sleeping but 3 of the 5 awoke moderately well rested. (Modified author abstract)
Treatment of Depression
Shealy, C, et al, Depression: A diagnostic,
neurochemical profile and therapy with CES, J of Neuro. & Ortho. Med Surg.
10(4): 319-21, 1989.
Treatment of Anxiety
Schmitt, R. Capo, T. & Boyd, E. CES as a
treatment for anxiety in chemically dependent persons. Alcoholism: Clinical and
experimental Research. 10(2): 158-160, 1986.
Drug abuse - Modification of brain wave activity
Braverman, E. & Blum, K. Modification of P300 amplitude and other electrophysiological parameters of drug abuse. Cur Ther Res. 48(4): 586-56, 1990.
Device: HealthPax, 100 Hz, 20% duty cycle, 1.0 mA, no dc bias, square waves, electrodes at left wrist and forehead.
P300 waves have a reduced amplitude in many alcoholics, which does not revert to normal, even after continued abstinence. 13 alcohol and/or drug abusers and 2 staff controls were selected as they entered the clinic for a computerized EEG. All were given 40 minutes of CES between pre and post EEG. There were no significant changes in the controls. Following the CES the patient's P300 amplitude increased significantly (P<.05). The time went from a pretreatment of 308 to 317 msec post-treatment. The amplitude (dV) sent from pretreatment of 7.0 to 9.9 post-treatment. Also there were significant positive shifts in alpha, delta, theta and beta spectra in patients who were abnormal in one or more of these areas prior to CES treatment. It was concluded that CES might be a significant non-drug treatment for the underlying electrophysiological disorder of the drug abuser, because the normalization of these electrophysiological parameters are characteristic of pharmaceutical treatment. (Modified author abstact)
Health Pax Specifications
Health Pax pulse rate frequencies - 100 hz are
selected by sliding a switch in the battery compartment. Individuals may use
both settings to determine which frequency provides the best results. These two
pulse rates have been used historically in other CES devices over the past 30
years. Health Pax offers three timer selections of 30 minutes, 45 minutes or
continuous operation. Following the initial series of Health Pax applications,
the device may be used on occasion as needed to maintain the achieved level of
improvements. Normally, CES is used Once or Twice
Health Pax Features
This item is NEW and offers the original 100 Hz frequency
One Year Warranty - Parts & Labor
45 Day Satisfaction Guarantee - 15% Restocking Fee
The BT7 Bio-Tuner is the upgraded version of the BT6 and offers 6 different user-selectable Modes settings, a digitally-controlled 20 minute automatic shut-off timer, and a Low Battery warning light. The BT7 is microchip controlled and includes a quartz crystal timer to ensure stable and precise frequencies.
Available Mode functions for the BT7:
Maximum <1.5mA Peak ~40 Volts Peak-Peak into typical 4k ohm load. Minimum <~10 microamperes, 10 Volt Peak-Peak at lowest setting. Output impedance ~20k ohm. Modified rectilinear wave with rapid rise time (under 1uS). There are over 500 harmonic frequencies delivered in each pulse as observed on a frequency domain (not time domain) spectrum analyzer. Base waveform (Mode 1) 1,000 Hz Square wave (+/- 1%) pulse-modulated by 111.11 Hz (+/- 1%) Square wave. Waveforms are Microchip Quartz Crystal-Controlled for precise frequency output. There are 6 user-selectable output Modes. 9-Volt DC Alkaline Battery operation, useful to end voltage ~6.2 Volts. Battery drain: minimum ~9mA @ 9 Volts to maximum of 30mA with output fully loaded. Auto-shutoff time of 20 minutes. Controlled digitally. Pulses are Bi-Phasic (AC) with no DC or offset bias. Output is transformer coupled so that no direct current can appear at electrodes. The algebraic sum of positive and negative-going pulses is zero. This obviates any possibility of electrolysis, ion migration, or polarization. Low battery indicator. Low battery circuitry illuminates Red LED light when battery voltage falls below 5.2 Volts. Output is disabled when low battery condition present.
Each BT7 includes:
NOTE: The Canadian Health Protection Branch has issued a Medical Device License
(#30096-409510) for the BT7 Bio-Tuner. The Bio-Tuner is classified as a Class
II Medical Device, allowing for sale without a Medical Doctor's prescription.
New variable frequency Oasis allows you to manually adjust
the strobe rate from 1 hz to 20 hz, when used without your light and sound
machine. Works with Orion, Proteus, and Paradise.